Multiparameter scoring system for the prognosis of differentiated thyroid cancer

Summary The aim of the study was to develop a scoring system consisting of multiple parameters that are significant for prognosis of thyroid cancer. The score was designed to permit a risk stratification with all available information at any time of presentation. Patients, methods: A score using 25 parameters was used for 171 patients with differentiated thyroid cancer, who were included in follow up over a mean of 9 (± 5) years. The significance of each parameter as well as of a summation outcome score was determined. The result of this scoring system was compared to other scores reported in the literature applied to the same patients' group. Thirty-two out of the 171 patients presented with recurrence during follow up. Results: The summation score was highly significant for prognosis of differentiated thyroid cancer. Out of 25 parameters, 18 showed a significant association with outcome also as individual parameters. In comparison to the scores commonly used, this new system showed the highest significance (p < 0.0001, chi square 90, df 1) to estimate recurrence free survival. At a cutoff of –5.95 the sensitivity and specificity for the distinction between high and low risk patients were 87.5 and 77.0%, respectively. Conclusion: With our multiparameter scoring system a reliable prognosis with respect to recurrence free survival is possible in patients suffering from differentiated thyroid cancer. A summation score of all parameters gives the best results. Scoring is also possible, if several important parameters are missing.

[1]  Tae Yong Kim,et al.  Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. , 2005, The Journal of clinical endocrinology and metabolism.

[2]  A. Al-nahhas Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals , 2004, Nuclear medicine communications.

[3]  O. Schober,et al.  Overtherapy or undertherapy for papillary thyroid microcarcinoma? Therapeutic considerations for radioiodine ablation , 2004 .

[4]  J. Wu,et al.  Prognostic scoring systems in patients with follicular thyroid cancer: a comparison of different staging systems in predicting the patient outcome. , 2004, Thyroid : official journal of the American Thyroid Association.

[5]  A. Miyauchi,et al.  Encapsulated Anaplastic Thyroid Carcinoma Without Invasive Phenotype with Favorable Prognosis: Report of a Case , 2003, Surgery Today.

[6]  C. Hsueh,et al.  Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas , 2002, Journal of surgical oncology.

[7]  I. Fleming,et al.  A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985‐1995 , 1998, Cancer.

[8]  H. Hundeshagen,et al.  [Low-risk thyroid carcinoma--therapy, follow-up and prognosis]. , 1997, NuclearMedicine.

[9]  R. Fimmers,et al.  Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  H. Evans Encapsulated columnar-cell neoplasms of the thyroid. A report of four cases suggesting a favorable prognosis. , 1996, The American journal of surgical pathology.

[11]  E. Germann,et al.  An evaluation of prognostic scoring systems in patients with follicular thyroid cancer. , 1995, American journal of surgery.

[12]  J. Hanke,et al.  [18FDG whole-body PET in differentiated thyroid carcinoma. Flipflop in uptake patterns of 18FDG and 131I]. , 1995, Nuklearmedizin. Nuclear medicine.

[13]  R. Hruban,et al.  Follicular variant of papillary thyroid carcinoma. A clinicopathologic study , 1994, Cancer.

[14]  E. Bergstralh,et al.  Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.

[15]  B. Cady,et al.  An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.

[16]  W. Taylor,et al.  Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. , 1987, Surgery.

[17]  M. van Glabbeke,et al.  A prognostic index for thyroid carcinoma. A study of the E.O.R.T.C. Thyroid Cancer Cooperative Group. , 1979, European journal of cancer.

[18]  Daan Brandenbarg The National. , 1892 .

[19]  B. de Keizer,et al.  Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. , 2005, European journal of endocrinology.